Creafund supports VHC's ambitious buy-and-build strategy
During January 2019 Creafund has reached a partnership agreement with Vision Healthcare and the managers of Mylène NV regarding the sale of Mylène NV and the subsequent reinvestment of a substantial part of the proceeds in Vision Healthcare in order to support Vision Healthcare's overall strategy of becoming a leading platform (through buy-and-build) in the direct-to-consumer (D2C) business.
Vision Healthcare is an ambitious consumer healthcare company with a large portfolio of self-care brands and OTC products in several European countries. Vision Healthcare strongly focuses on an omnichannel approach through which its brands are marketed, with a specific focus on emerging digitalized and direct-to-consumer channels. Brands connect with the consumer through channels such as retail, direct e-commerce, marketplaces (Amazon, Bol.com, …), social media and influencers, mail order & catalogues, home parties and teleshopping. This enables Vision Healthcare to deliver both personalized and convenient customer experiences. Vision Healthcare is operating as a consolidator in the European landscape, whilst allowing group brands to benefit from a shared platform allowing sustainable organic expansion. The company is actively pursuing a buy-and-build strategy, anchored in a deep understanding of today’s macro-economic trends such as shifting channel dynamics & digital brand building, the increasing consumer self-medication and natural/organic products. The M&A strategy is designed to complement the current Vision Healthcare platform, of which the various components reinforce one another, with the capability of effectively supporting and enlarging any existing company or stand-alone brand.